Intracellular cytokine patterns of peripheral blood T cells as a useful indicator of activeness of Crohn's disease

Hiroshima Journal of Medical Sciences

Volumn 54, Issue 1, 2005, Pages 1-8

  Ogura, Yoshio ^a   Imamura, Yuji ^a   Murakami, Yoshiaki ^a   Takesue, Yoshio ^a   Yokohama, Takashi ^b   Sueda, Taijiro ^a   Hiyama, Eiso ^c  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Aki City Hospital   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

CD45RO; Crohn's disease; Cytokine; Helper T cells; Peripheral blood

Indexed keywords

CD3 ANTIGEN; CD45RO ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MONENSIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOSTIMULATION; LYMPHOCYTE COUNT; MALE; MEMORY CELL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

ADULT; CASE-CONTROL STUDIES; CROHN DISEASE; CYTOKINES; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 17644408067     PISSN: 00182052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Akagi, S., Hiyama, E., Imamura, Y., Takesue, Y., Matsuura, Y. and Yokoyama, T. 2000. Interleukin-10 expression in intestine of Crohn disease. Int. J. Mol. Med. 5: 389-395.
2. Asakura, H., Yao, T., Matsui, T., Koganei, K., Fukushima, T., Takazoe, M., Hobara, R., Nakano, H., Okamura, S., Matsueda, K., Kashida, H., Makiyama, K., Hiwatashi, N., Kashiwagi, K. and Hibi, T. 2001. Efficacy of treatment with chimeric monoclonal antibody (Infliximab) to tumor necrosis factor-alpha for Crohn's disease in Japan: evaluation by rapid turnover proteins, and radiologic and endoscopic findings. J. Gastroenterol. Hepatol. 16: 763-769.
3. Best, W.R., Becktel, J.M. and Singleton, J.W. 1976. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70: 439-444.
4. Breese, E. and MacDonald, T.T. 1995. TNF alpha secreting cells in normal and diseased human intestine. Adv. Exp. Med. Biol. 4: 371B821-824.
5. Breese, E.J., Michie, C.A., Nicholls, S.W., Murch, S.H., Williams, C.B., Domizio, P., Walker-Smith, J.A. and MacDonald, T.T. 1994. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106: 1455-1466.
6. Canioglio, L., Te Velde, A.A., Tigges, A.J., Das, P.K. and Van Deventer, S.J. 1998. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm. Bowel. Dis. 4: 285-290.
7. Dieckgraefe, B.K. and Korzenik, J.R. 2002. Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet 360: 1478-1480.
8. Fiocci, C. 1998. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 115: 182-205.
9. Fuss, I.J., Neurath, M., Boirivant, M., Klein, J.S., de la Motte, C., Strong, S.A., Fiocchi, C. and Strober, W. 1996. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157: 1261-1270.
10. Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C.A., Gassull, M., Binder, V., Finkel, Y., Cortot, A., Modigliani, R., Laurent-Puig, P., Gower-Rousseau, C., Macry, J., Colombel, J.F., Salibatou, M. and Thomas, G. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
11. Ito, H., Hirotani, T., Yamamoto, M., Ogawa, H. and Kishimoto, T. 2002. Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes T-cell apoptosis in a murine model of Crohn's disease. J. Gastroenterol. 37: 56-61.
12. Jason, J. and Lamed, J. 1997. Single-cell cytokine profiles in normal humans: comparison of flow cytometric reagents and stimulation protocols. J. Immunol. Methods 207: 13-23.
13. Jo, Y., Matsumoto, T., Yada, S., Fujisawa, K., Esaki, M., Onai, N., Matsushima, K. and Iida, M. 2003. CCR4 is an up-regulated chemokine receptor of peripheral blood memory CD4+ T cells in Crohn's disease. Clin. Exp. Immunol. 132: 332-338.
14. Kakazu, T., Hara, J., Matsumoto, T., Nakamura, S., Oshitani, N., Arakawa, T., Kitano, A., Nakatani, K., Kinjo, F. and Kuroki, T. 1999. Type 1 T-helper cell predominance in granulomas of Crohn's disease. Am. J. Gastroenterol. 94: 2149-2155.
15. Kirsner, J.B. and Shorter, R.G. 1995. Inflammatory bowel disease, 4th ed. Williams & Wilkins, Baltimore.
16. Korzenik, J.R. and Dieckgraefe, B.K. 2000. Is Crohn's disease an immunodeficiency? Dig. Dis. Sci. 45: 1121-1129.
17. Kosiewicz, M.M., Nast, C.C., Krishnan, A., Rivera-Nieves, J., Moskaluk, C.A., Matsumoto, S., Kozaiwa, K. and Cominelli, F. 2001. Th1-type responses mediate spontaneous ileitis in novel murine model of Crohn's disease. J. Clin. Inv. 107: 695-702.
18. Kucharzik, T., Stoll, R., Lugering, N. and Domschke, W. 1995. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 100: 452-456.
19. Mackay, C.R., Andrew, D.P., Briskin, M., Ringler, D.J. and Butcher, B.C. 1996. Phenotype, and migration properties of three major subsets of tissue homing T cells in sheep. Eur. J. Immunol. 26: 2433-2439.
20. Mayer, L. 2000. IBD: Inflammatory Bowel Disease. Mount Sinai Journal of Medicine 67: 208-213.
21. Meenan, J., Spaans, J., Grool, TA., Pals, S.T., Tytgat, G.N. and van Deventer, S.J. 1997. Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation. Gut 40: 241-246.
22. Monteleone, G., Biancone, L., Marasco, R., Morrone, G., Marasco, O., Luzza, F. and Pallone, F. 1997. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 112:1169-1178.
23. Hoser, M. and Murphy, K.M. 2000. Dendritic cell regulation of TH1-TH2 development. Nature Immunology 1:119-205.
24. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A. and Coffman, R.L. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357.
25. Mosmann, T.R. and Moore, K.W. 1991. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol. Today 12: A49-53.
26. Niessner, M. and Volk, B.A. 1995. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin. Exp. Immunol. 101: 428-435.
27. Noguchi, M., Hiwatashi, N., Liu, Z. and Toyota, T. 1998. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease. Gut 43: 203-209.
28. Ogura, Y., Inohara, N., Benito, A., Chen, F.F., Yamaoka, S. and Nunez, G. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276: 4812-4818.
29. Parronchi, P., Romagnani, P., Annunziato, F., Sampognaro, S., Becchio, A., Giannarini, L., Maggi, E., Pupilli, C., Tonelli, F. and Romagnani, S. 1997. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol. 150: 823-832.
30. Plevy, S.E., Landers, C.J., Prehn, J., Carramanzana, N.M., Deem, R.L., Shealy, D. and Targan, S.R. 1997. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J. Immunol. 159: 6276-6282.
31. Romagnani, P., Annunziato, F., Baccari, M.C. and Parronchi, P. 1997. T cells and cytokines in Crohn's disease. Curr. Opin. Immunol. 9: 793-799.
32. Roman, L.I., Manzano, L., De La Hera, A., Abreu, L., Rossi, I. and Alvarez-Mon, M. 1996. Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease. Gastroenterology 110:1008-1019.
33. Ruemmele, F.H., Dionne, S., Levy, E. and Seidman, E.G. 1999. Dexamethasone inhibits IFN gamma-induced MHC class II expression of intestinal epithelial cells independently of the TGF-beta1 regulatory pathway. Aliment. Pharmacol. Ther. 13: 595-601.
34. Sallusto, F. and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179: 1109-1118.
35. Selby, W.S. and Jewell, D.P. 1983. T lymphocyte subsets in inflammatory bowel disease:peripheral blood. Gut 24: 99-105.
36. Targan, S.R., Hanauer, S.B., van Deventer, S.J.H., Mayer, L., Present. D.H., Braakman, T., DeWoody, K.L., Schaible, T.F. and Rutgeerts, P.J. 1997. A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor for Crohn's disease. New Eng. J. Med. 337: 1029-1035.
37. Yamamoto, M., Yoshizaki, K., Kishimoto, T. and Ito, H. 2000. IL-6 is required for the development of Th1 cell-mediated murine colitis. J. Immunol. 164: 4878-4882.